ConductScience.org, home

Paper42226175

GGT-triggered self-immolative dexamethasone-oligopeptide prodrug nanoparticles ameliorate hepatic fibrosis via dual anti-inflammatory/immunomodulatory pathways with minimized systemic toxicity.

Zhu Z and 12 others. J Nanobiotechnology, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. GGT-triggered self-immolative dexamethasone-oligopeptide prodrug nanoparticles ameliorate hepatic fibrosis via dual anti-inflammatory/immunomodulatory pathways with minimized systemic toxicity. Papers, record 42226175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226175

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
GGT-triggered self-immolative dexamethasone-oligopeptide prodrug nanoparticles ameliorate hepatic fibrosis via dual anti-inflammatory/immunomodulatory pathways with minimized systemic toxicity.
PubMed
Journal
J Nanobiotechnology
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu ZZhi
2An JJin
3Zhang ZZijie
4Gao FFeng
5Liao DDongling
6Wang JJie
7Yin HHuoli
8Huang XXinran
9Kang KKaixuan
10Liu YYongji
11Duan XXingchen
12Xu BBing
13Lei HHaimin

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProdrugsMajor topic
NanoparticlesMajor topic
DexamethasoneMajor topic
gamma-GlutamyltransferaseMajor topic
Anti-Inflammatory AgentsMajor topic
Liver CirrhosisMajor topic
OligopeptidesMajor topic
Animals
Mice
Hepatic Stellate Cells
Humans
Male
Liver
Mice, Inbred C57BL

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82403682the National Natural Science Foundation of ChinaPubMed
82104365the National Natural Science Foundation of ChinaPubMed
82274082the National Natural Science Foundation of ChinaPubMed
100102Wellcome TrustUnited KingdomPubMed
100102Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134864115Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation.J Control Release2022https://conductscience.org/library/papers/34864115PubMed
240467841The spatial and temporal activation of macrophages during fibrosis.Nat Rev Immunol2025https://conductscience.org/library/papers/40467841PubMed
334136662Non-bonded force field model with advanced restrained electrostatic potential charges (RESP2).Commun Chem2020https://conductscience.org/library/papers/34136662PubMed
441034621Chitosan-encapsulated Aloe vera nanoparticles outperform carrier-free forms in enhancing MSCs therapy for amikacin nephrotoxicity.Sci Rep2025https://conductscience.org/library/papers/41034621PubMed
539864459Update in clinical science: Autoimmune hepatitis.J Hepatol2025https://conductscience.org/library/papers/39864459PubMed
632460113Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy.Eur J Med Chem2020https://conductscience.org/library/papers/32460113PubMed
724189300Protection of a new heptapeptide from Carapax trionycis against carbon tetrachloride-induced acute liver injury in mice.Chem Pharm Bull (Tokyo)2013https://conductscience.org/library/papers/24189300PubMed
837517452Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes.J Hepatol2023https://conductscience.org/library/papers/37517452PubMed
940535704Bioengineered platelet nanoplatform enables renal-targeted dexamethasone delivery for chronic nephritis therapy with dual anti-inflammatory/anti-fibrotic effects and minimized systemic toxicity.Bioact Mater2025https://conductscience.org/library/papers/40535704PubMed
1037109344Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience.J Clin Med2023https://conductscience.org/library/papers/37109344PubMed
1116200070Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol2005https://conductscience.org/library/papers/16200070PubMed
1233128017Molecular and cellular mechanisms of liver fibrosis and its regression.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33128017PubMed
1333096584γ-Glutamyltranspeptidase (GGT)-Activatable Fluorescence Probe for Durable Tumor Imaging.Angew Chem Int Ed Engl2021https://conductscience.org/library/papers/33096584PubMed
1439063116Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells.Int J Mol Sci2024https://conductscience.org/library/papers/39063116PubMed
1518654426Nanocarriers as an emerging platform for cancer therapy.Nat Nanotechnol2007https://conductscience.org/library/papers/18654426PubMed
1629727797Visualizing glioma margins by real-time tracking of γ-glutamyltranspeptidase activity.Biomaterials2018https://conductscience.org/library/papers/29727797PubMed
1730285414Tandem Enzymatic Self-Assembly and Slow Release of Dexamethasone Enhances Its Antihepatic Fibrosis Effect.ACS Nano2018https://conductscience.org/library/papers/30285414PubMed
1822070475Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.N Engl J Med2011https://conductscience.org/library/papers/22070475PubMed
1924515270Liposomal oxymatrine in hepatic fibrosis treatment: formulation, in vitro and in vivo assessment.AAPS PharmSciTech2014https://conductscience.org/library/papers/24515270PubMed
2029501581Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling.J Pharmacol Sci2018https://conductscience.org/library/papers/29501581PubMed

See all 48 referencesDownload CSV of references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LOC102724197102724197PubTator's text mininghttps://conductscience.org/library/genes/102724197NCBI Gene
SMAD34088PubTator's text mininghttps://conductscience.org/library/genes/4088NCBI Gene
STAT16772PubTator's text mininghttps://conductscience.org/library/genes/6772NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42226175

GET https://conductscience.org/api/papers/v1/42226175/references?page=2